Evaluating antirheumatic treatments using synovial biopsy: a recommendation for standardisation to be used in clinical trials
about
Immunopathology of synovitis: from histology to molecular pathwaysUltrasound-guided synovial biopsy: a systematic review according to the OMERACT filter and recommendations for minimal reporting standards in clinical studiesThe features of the synovium in early rheumatoid arthritis according to the 2010 ACR/EULAR classification criteriaExpression of Prostaglandin E2 Enzymes in the Synovium of Arthralgia Patients at Risk of Developing Rheumatoid Arthritis and in Early Arthritis PatientsFeatures of the synovium of individuals at risk of developing rheumatoid arthritis: implications for understanding preclinical rheumatoid arthritisSynovial explant inflammatory mediator production corresponds to rheumatoid arthritis imaging hallmarks: a cross-sectional study.MicroRNA-34a dependent regulation of AXL controls the activation of dendritic cells in inflammatory arthritisAbatacept reduces synovial regulatory T-cell expression in patients with psoriatic arthritis.Serum matrix metalloproteinase-3 as a noninvasive biomarker of histological synovitis for diagnosis of rheumatoid arthritis.Heterogeneous expression pattern of interleukin 17A (IL-17A), IL-17F and their receptors in synovium of rheumatoid arthritis, psoriatic arthritis and osteoarthritis: possible explanation for nonresponse to anti-IL-17 therapy?B-cell subsets in the joint compartments of seropositive and seronegative rheumatoid arthritis (RA) and No-RA arthritides express memory markers and ZAP70 and characterize the aggregate pattern irrespectively of the autoantibody status.Preclinical Potency and Biodistribution Studies of an AAV 5 Vector Expressing Human Interferon-β (ART-I02) for Local Treatment of Patients with Rheumatoid Arthritis.Cellular response to prosthetic wear debris differs in patients with and without rheumatoid arthritis.Serum Vaspin Levels Are Associated with the Development of Clinically Manifest Arthritis in Autoantibody-Positive Individuals.Is there a role of synovial biopsy in drug development?Assessment of synovitis to predict bone erosions in rheumatoid arthritis.Preclinical characterisation of the GM-CSF receptor as a therapeutic target in rheumatoid arthritis.Intimal lining layer macrophages but not synovial sublining macrophages display an IL-10 polarized-like phenotype in chronic synovitisExpression of chemokines CXCL4 and CXCL7 by synovial macrophages defines an early stage of rheumatoid arthritis.Inhomogeneity of immune cell composition in the synovial sublining: linear mixed modelling indicates differences in distribution and spatial decline of CD68+ macrophages in osteoarthritis and rheumatoid arthritisMicroRNA-155 influences B-cell function through PU.1 in rheumatoid arthritis.Histone deacetylase 3 regulates the inflammatory gene expression programme of rheumatoid arthritis fibroblast-like synoviocytesInflammatory cytokines epigenetically regulate rheumatoid arthritis fibroblast-like synoviocyte activation by suppressing HDAC5 expressionFMS-related tyrosine kinase 3 ligand (Flt3L)/CD135 axis in rheumatoid arthritisSynovitis in psoriatic arthritis: immunohistochemistry, comparisons with rheumatoid arthritis, and effects of therapy.Synovial tissue heterogeneity and peripheral blood biomarkers.Why is biologic therapy useful in spondyloarthritis? Knowledge from synovial immunopathologic studies of spondyloarthritis.The problem of choice: current biologic agents and future prospects in RA.Dominant B cell receptor clones in peripheral blood predict onset of arthritis in individuals at risk for rheumatoid arthritis.Synovial tissue research: a state-of-the-art review.Stromal cell markers are differentially expressed in the synovial tissue of patients with early arthritis.Btk inhibition suppresses agonist-induced human macrophage activation and inflammatory gene expression in RA synovial tissue explants.Synovial features of patients with rheumatoid arthritis and psoriatic arthritis in clinical and ultrasound remission differ under anti-TNF therapy: a clue to interpret different chances of relapse after clinical remission?Endoplasmic reticulum stress cooperates with Toll-like receptor ligation in driving activation of rheumatoid arthritis fibroblast-like synoviocytes.Disease-specific and inflammation-independent stromal alterations in spondylarthritis synovitis.Local synovial engagement of angiogenic TIE-2 is associated with the development of persistent erosive rheumatoid arthritis in patients with early arthritis.Inflammatory immune cell responses and Toll-like receptor expression in synovial tissues in rheumatoid arthritis patients treated with biologics or DMARDs.Transcriptional Profiling of Synovial Macrophages using Minimally Invasive Ultrasound-Guided Synovial Biopsies in Rheumatoid Arthritis.A clinically based protein discovery strategy to identify potential biomarkers of response to anti-TNF-α treatment of psoriatic arthritis.Paradoxical arthritis occurring during anti-TNF in patients with inflammatory bowel disease: histological and immunological features of a complex synovitis.
P2860
Q26781647-8CDB958C-3B1C-4E13-B0B9-F763D197C3A6Q26824354-97A70EE9-46E7-44A9-ACCB-0E864F38E7A0Q28483442-0E0E6D96-824A-4ECD-AF5F-D41FD79EB9B3Q28546899-456C5235-6F3E-404A-82D6-7FE1731E7B90Q33667747-6E35FC5A-7B33-4E79-9734-52DD913ADF2CQ33832629-02AA9769-C33D-4585-A375-C418704C6B7CQ33849824-235E90DE-87C0-4314-B720-EE29FC6931C0Q33876826-05442C0A-9ABB-4CFA-B7B8-621D4F59EC57Q34043042-3D206AD3-AA19-401C-8072-D450FB5DA4B5Q34937925-DB68A9D4-3F7A-442D-BC10-40844D583755Q35286950-331FF384-8ED9-4A72-8AA9-EDA545E370B9Q35673189-7BFCEABA-95AD-4F6D-9B70-A0F8464849E9Q35798932-A5FFD7C0-3B73-4D3B-9F6F-DE736C5B9AADQ35869383-85C6AE58-4C44-49AB-ACA7-C708B22DB477Q35994130-05F1F4FD-7F0B-4DD3-8BB4-242D8931A574Q36111299-409A2FC3-AB01-4096-8857-81D60A1D4CD2Q36150157-DAC52C6C-5586-4F80-815B-B5E42F19FE8BQ36245798-F9F7AC5C-583F-4ABA-825E-2C2425E11B15Q36761906-098E4A96-AF58-4BE7-982F-0D612AC95F47Q37099845-F8D16DC4-AC76-4318-8513-AD00ED332021Q37315021-9F50619B-2427-4C5E-9F37-B27BDB31FF51Q37604525-6762BF0F-229C-4822-8148-C7D5C0D6EDB2Q37679886-ADFA8C1C-F5EE-46FE-BB19-BC31CFE9DBA3Q37690021-5830F4DE-DBE1-4AAC-B387-8CAF557B6631Q37866683-EC0D653B-FA22-49C2-AA93-8B0C157BAFF2Q37918858-BDE415A8-2508-45DF-B538-E1501267BAA2Q38068590-F6F8DEB9-FC8B-4C25-A154-1C3136A56650Q38082588-2E7C2A37-ADD9-44C0-9135-F939443B0EC3Q38633322-75BD7A49-A05E-4B4D-A736-90EA7EF26352Q39431367-C16CEE8F-5789-4744-9D20-ADDBB32C0AFDQ40089035-A5DFB62A-9C9E-4AFC-AAC3-06E6AF5477C5Q40186747-905CAC4B-0574-4D23-87DE-272ED16A7522Q41146155-F5BED30C-0D33-4099-970F-A2C0B03E6054Q41711309-13BC42AD-2DE0-4449-9769-83CDB430B62EQ44547443-D396D293-ECC9-4B80-B2EB-7E734B7721AAQ44588146-D7AD21FC-02F3-460A-92CA-DF3D2B81074BQ46055310-40A5EF62-9793-4588-AFFF-756BF3E6B1D8Q50034711-8CC1B14A-BBB9-4E5B-BF0A-E2F8FBB656A0Q50960278-626C6CDA-E438-4FD8-856D-9C82664E781FQ52320824-3035FA4D-AE9D-4D3E-BA31-61CCC1718E34
P2860
Evaluating antirheumatic treatments using synovial biopsy: a recommendation for standardisation to be used in clinical trials
description
im November 2010 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 24 November 2010
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в листопаді 2010
@uk
name
Evaluating antirheumatic treat ...... to be used in clinical trials
@en
Evaluating antirheumatic treat ...... to be used in clinical trials
@nl
type
label
Evaluating antirheumatic treat ...... to be used in clinical trials
@en
Evaluating antirheumatic treat ...... to be used in clinical trials
@nl
prefLabel
Evaluating antirheumatic treat ...... to be used in clinical trials
@en
Evaluating antirheumatic treat ...... to be used in clinical trials
@nl
P2093
P50
P356
P1476
Evaluating antirheumatic treat ...... to be used in clinical trials
@en
P2093
Beatrijs M Lodde
Carlomaurizio Montecucco
Danielle M Gerlag
Elsa Vieira-Sousa
Ioana Felea
Marleen G H van de Sande
Paul Emery
Paul P Tak
Richard Reece
P304
P356
10.1136/ARD.2010.139550
P407
P50
P577
2010-11-24T00:00:00Z